Clinical trial
Preoperative Intravenous Ferric Carboxymaltose (Ferinject) in Patients With Orthopedic Surgery and High Risk of Blood Loss
NCT01345968 is registered in ClinicalTrials.gov with University Hospital Muenster as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Preoperative Intravenous Ferric Carboxymaltose (Ferinject) in Patients With Orthopedic Surgery and High Risk of Blood Loss
- Lead sponsor
- University Hospital Muenster
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- June 30, 2011
- Completion date
- February 28, 2013
- Enrollment
- 3 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
anemia, high risk of blood loss, orthopedic surgery